A PET/MRI is a hybrid imaging scan that combines two technologies into one session: PET (positron emission tomography), which tracks metabolic activity inside your body, and MRI (magnetic resonance imaging), which produces highly detailed pictures of soft tissues and organs. The result is a single scan that shows both what your tissues look like and how they’re functioning at a cellular level. It’s used primarily in cancer diagnosis, brain conditions, and heart disease.
How PET/MRI Works
The two halves of a PET/MRI do very different jobs. The PET side detects a small amount of radioactive tracer that’s injected into your bloodstream before the scan. This tracer is typically a form of sugar that collects in cells with high metabolic activity, like cancer cells, which burn through glucose faster than normal tissue. The scanner picks up the radiation signals from that tracer and maps where activity is highest.
The MRI side uses powerful magnets and radio waves to create detailed images of your body’s soft tissues. Unlike a CT scan, which uses X-rays and excels at showing bone, MRI provides superior contrast for things like brain tissue, muscles, ligaments, and internal organs. When these two data streams are captured at the same time and layered together, doctors can pinpoint not just where something abnormal is, but whether it’s metabolically active, which is often the key question in distinguishing a harmless irregularity from something that needs treatment.
Why PET/MRI Instead of PET/CT
PET/CT has been the standard hybrid scan for years, combining PET with a CT scan rather than an MRI. PET/MRI doesn’t replace it in every situation, but it has two notable advantages.
The first is radiation exposure. Because MRI uses magnets instead of X-rays, the MRI portion adds zero radiation. In a study of breast cancer patients, PET/MRI delivered roughly 50% less radiation than PET/CT, with total doses averaging about 9.3 millisieverts compared to 17.6 for PET/CT. That matters especially for patients who need repeated scans over time, like those being monitored during cancer treatment, and for children.
The second advantage is soft tissue detail. MRI simply sees soft tissue better than CT does. PET/MRI has shown higher sensitivity for detecting liver metastases and possibly bone metastases in breast cancer patients compared to PET/CT. It can also detect brain metastases that PET/CT may miss. The tradeoff: PET/CT remains better at spotting small lung nodules, because the lungs are full of air and moving constantly, which challenges MRI.
Cancer Diagnosis and Staging
Oncology is the most common reason for a PET/MRI. The scan helps doctors determine whether a tumor is present, how aggressive it appears based on its metabolic activity, and whether cancer has spread to other parts of the body. The MRI component’s superior soft tissue contrast makes it particularly valuable for cancers in the brain, head and neck, pelvis, and liver, where distinguishing tumor from surrounding tissue is critical.
For pediatric cancer patients, PET/MRI is especially appealing. Children are more sensitive to radiation, so cutting the dose in half is meaningful. Young children also often require general anesthesia for imaging, and combining PET and MRI into a single session means one round of sedation instead of two separate procedures. Several major medical centers now prioritize PET/MRI for pediatric brain tumors for exactly these reasons.
Brain and Neurological Conditions
PET/MRI plays a growing role in evaluating dementia, epilepsy, and brain tumors. In neuro-oncology, the scan helps distinguish tumor recurrence from changes caused by radiation therapy or surgery, which can look similar on MRI alone. Adding the metabolic information from PET helps clarify whether abnormal-looking tissue is actually active disease.
In Alzheimer’s disease evaluation, specialized PET tracers can detect amyloid plaques, one of the hallmark proteins of the disease. A negative amyloid PET scan is useful for ruling out Alzheimer’s when the cause of cognitive decline is unclear. In one clinical series of older adults with epilepsy and cognitive impairment, amyloid PET results helped reduce diagnostic uncertainty in a third of the cases studied. When this amyloid data is combined with the structural detail from MRI in a single session, doctors get a more complete picture of both the brain’s structure and its underlying pathology.
Heart Disease
In cardiology, PET/MRI is proving valuable for inflammatory heart conditions, particularly cardiac sarcoidosis, a disease where clusters of immune cells form in the heart muscle. The MRI component detects scarring and fibrosis in the heart wall, while PET reveals areas of active inflammation. Together, a single PET/MRI scan can differentiate between active disease and old, healed damage, a distinction that directly affects treatment decisions. The combined scan has also shown promise in evaluating ischemic heart disease and certain types of cardiomyopathy.
What the Scan Feels Like
The entire process takes about two hours from arrival to departure, though the actual time inside the scanner is around 45 minutes. You’ll need to stop eating about four hours before the scan and avoid strenuous exercise for a couple of days beforehand, both of which ensure the radioactive tracer distributes properly.
When you arrive, a technologist places a small IV line and injects the tracer. You then rest quietly in a reclining chair for 30 to 60 minutes while the tracer circulates and accumulates in your tissues. Talking, reading, or using your phone during this period can cause the tracer to concentrate in muscles you’re using, which can create misleading signals on the scan.
Once you’re in the scanner, you lie on a padded table that slides into a large, tube-shaped machine. It looks and sounds like a standard MRI: expect loud knocking and humming noises, and you’ll be given earplugs or headphones. You need to stay as still as possible. One technical advantage of PET/MRI is that the system can use motion data from the MRI to correct for small movements in the PET images, improving image quality compared to standalone PET scans. After the procedure, the small amount of radioactive tracer leaves your body naturally over the next several hours.
Who Cannot Have a PET/MRI
Because the scan involves a powerful magnet, anything metallic in or on your body is a potential safety concern. Certain implants are absolute contraindications, meaning the scan cannot be performed. These include most pacemakers and implantable defibrillators, cochlear implants, certain neurostimulation devices, and drug infusion pumps such as insulin pumps. Metallic foreign bodies are also a concern: if you have a history of metal fragments near your eyes from welding or facial trauma, you’ll need an X-ray to confirm it’s safe before proceeding.
Other items that must be removed or evaluated include metallic catheters, cerebral aneurysm clips, magnetic dental implants, tissue expanders with magnetic ports, hearing aids, and body piercings. Your imaging team will screen you thoroughly before the scan. Some newer implants are labeled “MRI-conditional,” meaning they can be safely scanned under specific conditions, but this must be verified on a case-by-case basis.
Cost and Availability
PET/MRI scanners are expensive to purchase and operate, so they’re found mainly at large academic medical centers and specialized cancer hospitals rather than community imaging facilities. PET scans in general cost between $1,300 and $4,600 or more without insurance. Medicare’s national average for an outpatient PET scan is around $920 at a freestanding facility or about $1,600 at a hospital outpatient department. Most insurers and Medicare require prior authorization before covering a PET scan, so your referring doctor typically needs to submit documentation explaining why the scan is medically necessary. PET/MRI may face additional coverage hurdles compared to the more established PET/CT, depending on your insurer and the specific clinical indication.